Brentview Investment Management LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 40,843 shares of the financial services provider's stock, valued at approximately $9,485,000. CME Group makes up approximately 5.4% of Brentview Investment Management LLC's portfolio, making the stock its 3rd biggest position.
A number of other hedge funds have also made changes to their positions in CME. Franklin Resources Inc. boosted its stake in CME Group by 70.4% during the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider's stock valued at $544,157,000 after purchasing an additional 1,003,119 shares during the period. International Assets Investment Management LLC boosted its position in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider's stock valued at $1,072,070,000 after acquiring an additional 483,618 shares during the period. Canoe Financial LP boosted its position in shares of CME Group by 698.0% in the fourth quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider's stock valued at $126,384,000 after acquiring an additional 476,019 shares during the period. Janus Henderson Group PLC grew its stake in shares of CME Group by 17.8% in the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider's stock worth $554,707,000 after acquiring an additional 380,071 shares during the last quarter. Finally, Baillie Gifford & Co. bought a new position in CME Group during the third quarter worth $79,692,000. Institutional investors and hedge funds own 87.75% of the company's stock.
Wall Street Analyst Weigh In
CME has been the topic of several research analyst reports. Citigroup lowered shares of CME Group from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Piper Sandler lifted their target price on CME Group from $250.00 to $258.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 7th. Barclays upped their price target on CME Group from $231.00 to $257.00 and gave the company an "equal weight" rating in a report on Monday, December 9th. Deutsche Bank Aktiengesellschaft decreased their price objective on CME Group from $227.00 to $226.00 and set a "hold" rating on the stock in a report on Monday, November 11th. Finally, Oppenheimer upped their target price on CME Group from $245.00 to $258.00 and gave the company an "outperform" rating in a research note on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, CME Group has a consensus rating of "Hold" and an average price target of $229.27.
View Our Latest Report on CME Group
CME Group Trading Up 0.3 %
NASDAQ CME opened at $236.52 on Monday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02. The stock has a 50-day simple moving average of $234.73 and a 200 day simple moving average of $222.63. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $85.23 billion, a PE ratio of 24.87, a P/E/G ratio of 5.37 and a beta of 0.57.
CME Group Increases Dividend
The company also recently declared a dividend, which was paid on Thursday, January 16th. Investors of record on Friday, December 27th were given a $5.80 dividend. This is an increase from CME Group's previous dividend of $2.50. The ex-dividend date of this dividend was Friday, December 27th. CME Group's dividend payout ratio (DPR) is currently 48.37%.
CME Group announced that its board has approved a share buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's leadership believes its shares are undervalued.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
